| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |